LJ Fairbairn - Concepedia

Author

LJ Fairbairn

Cancer Research UK Manchester Institute

Also Known As

L Fairbairn, L J Fairbairn, L. J. Fairbairn, L.J Fairbairn, L.J. Fairbairn, LJ Fairbairn

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Cancer Research UK Manchester Institute The Christie NHS Foundation Trust The Christie Hospital University of Manchester Royal Manchester Children's Hospital

About

LJ Fairbairn is an author at Cancer Research UK Manchester Institute specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	793
2	Cell Biology	10	10	675
3	Health Sciences	3	3	466
4	Natural Sciences	2	2	40
5	Biochemistry	2	2	47

LJ Fairbairn

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Suppression of apoptosis allows differentiation and development of a multipotent hemopoietic cell line in the absence of added growth factors LJ Fairbairn, G.J. Cowling, Birgit M. Reipert, Cell Developmental BiologyCell DivisionMedicineApoptosisBlood Cell	1993	373
CD34<sup>+</sup>AC133<sup>+</sup>Cells Isolated from Cord Blood are Highly Enriched in Long‐Term Culture‐Initiating Cells, NOD/SCID‐Repopulating Cells and Dendritic Cell Progenitors Erika A. de Wynter, David Buck, Claire A. Hart, Stem Cells	1998	210
Genotoxicity studies on the azo dye Direct Red 2 using the in vivo mouse bone marrow micronucleus test P. Rajaguru, LJ Fairbairn, J. Ashby, Mutation Research/Genetic Toxicology and Environmental Mutagenesis Bone Marrow FailureMedicineHematologyBlood CellToxicology	1999	68
Human monocytes expressing a CEA-specific chimeric CD64 receptor specifically target CEA-expressing tumour cells in vitro and in vivo Alireza Biglari, T. D. Southgate, LJ Fairbairn, Gene Therapy Cancer ImmunosurveillanceMedicineCea-expressing Tumour CellsImmunologyImmunologic Mechanism	2006	62
Long-term in vitro correction of alpha-L-iduronidase deficiency (Hurler syndrome) in human bone marrow. LJ Fairbairn, L. S. Lashford, Elaine Spooncer, Proceedings of the National Academy of Sciences Cell TherapyImmunologyPathologyHurler SyndromeBone Marrow Failure	1996	48
Chemoprotective gene transfer II: multilineage in vivo protection of haemopoiesis against the effects of an antitumour agent by expression of a mutant human O6-alkylguanine-DNA alkyltransferase N. Chinnasamy, JA Rafferty, Ian Hickson, Gene Therapy Chemoprevention StrategyOncogenic AgentAnti-cancer AgentAntitumour AgentRadiation Oncology	1998	46
Long-term protection of hematopoiesis against the cytotoxic effects of multiple doses of nitrosourea by retrovirus-mediated expression of human O6-alkylguanine-DNA-alkyltransferase LJ Fairbairn, TM Dexter, JA Rafferty, Blood	1996	45
Chemoprotective gene transfer I: transduction of human haemopoietic progenitors with O6-benzylguanine-resistant O6-alkylguanine-DNA alkyltransferase attenuates the toxic effects of O6-alkylating agents in vitro Ian Hickson, LJ Fairbairn, N. Chinnasamy, Gene Therapy O6-alkylating AgentsOncogenic AgentToxic EffectsChemoprotective Gene TransferGenetics	1998	34
A novel dual function retrovirus expressing multidrug resistance 1 and O6-alkylguanine-DNA-alkyltransferase for engineering resistance of haemopoietic progenitor cells to multiple chemotherapeutic agents Joseph A. Rafferty, Radek Čmejla, Markus Hildinger, Gene Therapy Chemotherapeutic AgentsDrug ResistanceMedicineHuman RetrovirusImmunology	1999	31
Complete cDNA sequence of human foetal liver peroxisomal 3-oxoacyl-CoA thiolase LJ Fairbairn, M J A Tanner Nucleic Acids Research PathologyMolecular BiologyRedox BiologyHematologyBiochemical Genetics	1989	25

Page 1